Drug intelligence / Profile preview

He Ling

Development stage: Preclinical
Lead developer: Shanghai Skin Disease Hospital
Modality: Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

He Ling is a cream developed by Shanghai Skin Disease Hospital and Hainan Kangzhe Beauty Technology Co., Ltd. It is being investigated for its efficacy in treating post-acne atrophic scars following non-ablative fractional laser therapy. The cream is described as a soothing, moisturizing, and repairing formulation.

Brand names: 禾零舒缓保湿修复霜
Other names: Heling Cream

Beyond the preview

Go deeper on He Ling.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on He Ling.

Explore the full profile